Apoliprotein E genotype and its relation to behavioral and psychological symptoms in Alzheimer's disease;Genotyp apolipoproteiny E a zaburzenia zachowania i objawy psychotyczne w chorobie Alzheimera

Postepy Psychiatrii i Neurologii

Volumn 16, Issue 3, 2007, Pages 215-220

  Sobów, Tomasz ^a   Kłoszewska, Iwona ^a   Flirski, Marcin ^a   Golańska, Ewa ^b   Liberski, Paweł P ^b  

^a Uniwersytetu Medyzcnego ^*  (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Delusions; Genotyp; Psychosis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; AGGRESSION; ALLELE; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HALLUCINATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRY; PATIENT SELECTION; PREVALENCE; PSYCHOMETRY; RATING SCALE; RESTLESSNESS; RISK ASSESSMENT; SYMPTOM;

EID: 77953410540     PISSN: 12302813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber G, Ross AD. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
3. Kieszek S, Lalowski M, Bratosiewicz J, Czyzewski K, Pfeffer A, Sobow T, Kloszewska I, Liberski PP, Barcikowska M. Apolipoprotein E genotypes in Alzheimer's disease in central Poland. Alzheimer's Rep 1999; 2: 155-8.
4. Paradowski B, Szczepaniak M, Dobosz T, Sasiadek M. Apolipoproteina E i białko tau w otepieniu typu Alzheimera. Pol Merk Lek 2000; 9: 758-9.
5. Łuczywek E, Pfeffer A, Nowicka A, Czyżewski K, Łałowski M, Styczyńska M, Barcikowska M. Wzorce aktywności poznawczej a polimorfizm apoliproteiny E w chorobie Alzheimera. Neurol Neurochir Pol 2001; 35: 1033-45.
6. Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM. Apolipoprotein E, amyloid and Alzheimer's disease. Mol Interv 2002; 2: 363-75.
7. Lehtovirta M, Laakso MP, Frisoni GB, Soininen H. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 2000; 21: 293-300.
8. Aerssens J, Raeymaekers P, Lilienfeld S, Geerts H, Konings F, Parys W. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12: 69-77.
9. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 2005; 62: 454-9.
10. Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord 2006; 22: 73-82.
11. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hanninen T, Ryynanen M, Riekkinen PJ. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996; 46: 413-9.
12. Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Dement Geriatr Cogn Disord 2004; 18: 125-31.
13. Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, Stern Y, Mayeux R. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47: 256-9.
14. Ballard C, Massey H, Lamb H, Morris C. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997; 63: 273-4.
15. Weiner MF, Vega G, Risser RC, Honig LS, Cullum CM, Crumpacker D, Rosenberg RN. Apolipoprotein E epsilon4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999; 45: 633-8.
16. Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Duara R. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry 1999; 7: 119-23.
17. Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002; 58: 1182-8.
18. Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, Garman KS, van Dyck CH. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology 2007; 32: 171-9.
19. Hirono N, Mori E, Yasuda M, Imamura T, Shimomura T, Hashimoto M, Yamashita H. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1999; 11: 66-70.
20. Levy ML, Cummings JL, Fairbanks LA, Small GW. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry 1999; 45: 422-5.
21. Gabryelewicz T, Religa D, Styczynska M, Peplonska B, Pfeffer A, Wasiak B, Luczywek E, Golebiowski M, Androsiuk W, Czyzewski K, Przekop I, Barcikowska M. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement Geriatr Cogn Disord 2002; 14: 208-12.
22. Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Acta Psychiatr Scand 2006; 113: 59-63.
23. Craig D, Hart DJ, McCool K, McIlroy SP, Passmore AP. Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1327-30.
24. Muller-Thomsen T, Arlt S, Ganzer S, Mann U, Mass R, Naber D, Beisiegel U. Depression in Alzheimer's disease might be associated with apolipoprotein E e4 allele frequency in women but not in men. Dement Geriatr Cogn Disord 2002; 14: 59-63.
25. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32: 9-16.
26. Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8 (supl 3): 497-500.
27. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8: 29-34.
28. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry 2003; 54: 353-62.
29. Sweet RA, Kamboh MI, Wisniewski SR, Lopez OL, Klunk WE, Kaufer DI, DeKosky ST. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. J Geriatr Psychiatry Neurol 2002; 15: 24-30.
30. van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 2007; 23: 42-6.
31. Cummings JL, McRae T, Zhang R. Donepezil-Sertraline Study Group. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry 2006; 14: 605-12.
32. Cummings JL, Koumaras B, Chen M, Mirski D. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study. Am J Geriatr Pharmacother 2005; 3: 137-48.
33. Tariot PN, Profenno LA, Ismail MS. Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry 2004; 65 (supl 11): 11-5.
34. Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, Bentham P, Lendon CL. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78: 123-6.